Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysis

Objectives: To meta-analyse the clinical efficacy of piperacillin-tazobactam vs. carbapenems for treating hospitalized patients affected by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales bloodstream infections (BSIs). Methods: Two authors independently searched PubMed-MEDLINE and...

Cijeli opis

Bibliografski detalji

Glavni autori:	Milo Gatti, Pier Giorgio Cojutti, Federico Pea
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-12-01
Serija:	Journal of Global Antimicrobial Resistance
Teme:	Esbl-producing Enterobacterales Bloodstream infections Piperacillin-tazobactam Carbapenems Mortality rate
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2213716524001541
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!